Debra G. Goodwin

472 total citations
7 papers, 257 citations indexed

About

Debra G. Goodwin is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Debra G. Goodwin has authored 7 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 1 paper in Pharmacology. Recurrent topics in Debra G. Goodwin's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Immune Cell Function and Interaction (2 papers). Debra G. Goodwin is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Immune Cell Function and Interaction (2 papers). Debra G. Goodwin collaborates with scholars based in United States, United Kingdom and Canada. Debra G. Goodwin's co-authors include Cheryl Nickerson‐Nutter, Kathleen Shields, Lynette A. Fouser, Mary Collins, Debra D. Pittman, Yijun Carrier, Kyriaki Dunussi‐Joannopoulos, Scott H. Schelling, Spencer C. Liang and Hak‐Ling Ma and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Neuropharmacology.

In The Last Decade

Debra G. Goodwin

7 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra G. Goodwin United States 5 108 92 45 27 25 7 257
Benjamin Kühn United States 10 135 1.3× 127 1.4× 25 0.6× 49 1.8× 34 1.4× 19 334
K Last-Barney United States 10 192 1.8× 104 1.1× 52 1.2× 49 1.8× 40 1.6× 24 405
Krystal Herman United States 6 112 1.0× 68 0.7× 19 0.4× 42 1.6× 11 0.4× 6 214
Susan Fish United States 8 102 0.9× 74 0.8× 71 1.6× 28 1.0× 22 0.9× 9 350
Kazushi Araki Japan 12 78 0.7× 264 2.9× 25 0.6× 49 1.8× 13 0.5× 24 379
Jean-Pierre Evenou Switzerland 6 61 0.6× 190 2.1× 79 1.8× 59 2.2× 15 0.6× 7 323
Alamelu Chandrasekaran United States 5 71 0.7× 83 0.9× 36 0.8× 31 1.1× 31 1.2× 8 213
Fernando Salgado-Polo Netherlands 10 44 0.4× 209 2.3× 30 0.7× 21 0.8× 32 1.3× 12 301
Antonio Giampietri Italy 13 199 1.8× 102 1.1× 44 1.0× 91 3.4× 27 1.1× 30 397
Steven C. Gilman United States 10 133 1.2× 92 1.0× 41 0.9× 93 3.4× 37 1.5× 15 364

Countries citing papers authored by Debra G. Goodwin

Since Specialization
Citations

This map shows the geographic impact of Debra G. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra G. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra G. Goodwin more than expected).

Fields of papers citing papers by Debra G. Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra G. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra G. Goodwin. The network helps show where Debra G. Goodwin may publish in the future.

Co-authorship network of co-authors of Debra G. Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Debra G. Goodwin. A scholar is included among the top collaborators of Debra G. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra G. Goodwin. Debra G. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Liang, Spencer C., Cheryl Nickerson‐Nutter, Debra D. Pittman, et al.. (2010). IL-22 Induces an Acute-Phase Response. The Journal of Immunology. 185(9). 5531–5538. 135 indexed citations
2.
Nickerson‐Nutter, Cheryl, Debra G. Goodwin, Marina W. H. Shen, et al.. (2010). The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid. Neuropharmacology. 60(4). 633–641. 5 indexed citations
3.
MacLeod, Heather, et al.. (2010). The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice. Cellular Immunology. 266(1). 14–23. 4 indexed citations
4.
Liang, Spencer C., Debra D. Pittman, Yijun Carrier, et al.. (2009). IL-22, A Th17 Cytokine, induces a systemic acute phase response. Cytokine. 48(1-2). 36–37. 2 indexed citations
5.
Chen, Lih-Ren, Weiheng Wang, Katherine L. Lee, et al.. (2009). Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A2α Inhibitors. Journal of Medicinal Chemistry. 52(4). 1156–1171. 16 indexed citations
6.
Lee, Katherine L., Mark L. Behnke, Megan A. Foley, et al.. (2007). Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy. Bioorganic & Medicinal Chemistry. 16(3). 1345–1358. 26 indexed citations
7.
Lee, Katherine L., Megan A. Foley, Lih-Ren Chen, et al.. (2007). Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α. Journal of Medicinal Chemistry. 50(6). 1380–1400. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026